Skip to content

AYURVEDIC TREATMENT FOR SEVERE RESPIRATORY DISORDERS

CLINICAL STUDY ON ROLE OF AGASTYA HARITAKI RASAYANA IN THE MANAGEMENT OF CHRONIC BRONCHITIS

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003872
Enrollment
60
Registered
2013-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic bronchitis

Interventions

Intervention1: Agastya Haritaki rasayana: orally 10 gm bd before food with warm water for 3 months follow up 1 month Control Intervention1: Vyaghri haritaki rasayana: orally 10 gm bd before food with

Sponsors

POST GRADUATE TEACHING HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged between 16 to 70 years Patients with history of uncomplicated Chronic Bronchitis Patient willing and able to participate in the study for 12 weeks

Exclusion criteria

Exclusion criteria: Patients suffering from Acute Bronchitis Patients having PEFR more than 50 percentage of the predicted value Presence of other pulmonary diseases like severe Emphysema Cor-pulmonale Cyanosis Pneumonia Asthma Cystic fibrosis Active Tuberculosis Lung cancer etc Patients with poorly controlled Diabetes Mellitus Patients with poorly controlled Hypertension History of hypersensitivity to the trial drug or any of its ingredients Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Change in the clinical symptoms of chronic bronchitis like Productive cough Dyspnoea Wheezing Chest Pain Nasal Congestion etc Timepoint: 3 MONTHS STUDY 1 MONTH FOLLOW UP

Secondary

MeasureTime frame
Change in St George s Respiratory Questionnaire SGRQ scoresTimepoint: 3 MONTHS STUDY 1 MONTH FOLLOW UP

Countries

India

Contacts

Public ContactPROF DR M S BAGHEL

IPGT AND RA

keshavamdkc@gmail.com08140872744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026